Aptamer Group plc (APTA) ORD GBP0.0001
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
Director dealings: Conygar, Aptamer insiders buy shares
13 January 2025 14:57
(Sharecast News) - Two director share purchases disclosed to the market in London on Monday involved insiders at the Conygar Investment Company and Aptamer Group.
-
Aptamer strikes new development contract agreement
19 December 2024 10:19
(Sharecast News) - Life sciences group Aptamer has struck a new development contract agreement with a rare disease biopharmaceutical company worth up to £155,000.
-
Aptamer appoints three new members to scientific board
6 December 2024 13:30
(Sharecast News) - Aptamer Group announced the appointment of three new members to its scientific advisory board on Friday, as it advanced the commercialisation of its 'Optimer' binders for life...
-
Aptamer reports progress since July fundraise
29 November 2024 10:46
(Sharecast News) - Aptamer Group, the developer of 'Optimer' binders for the life sciences industry, flagged solid operational progress in an update on Friday, reporting that since its £2.6m...
-
Aptamer extends contract with Unilever
3 September 2024 08:06
(Sharecast News) - Custom antibody alternatives business Aptamer said on Tuesday that it has extended its contract with household goods giant Unilever to progress its Optimer asset for deodorant development.
-
Aptamer reports success in ongoing work with Unilever
8 July 2024 10:49
(Sharecast News) - Aptamer Group, a developer of novel 'Optimer' binders for the life sciences industry, updated the market on its ongoing partnership with Unilever on Monday, aimed at creating...
-
Aptamer enters partnership with Microsaic Systems
14 June 2024 14:15
(Sharecast News) - Aptamer Group announced a partnership with Microsaic Systems on Friday, to develop a panel of Optimer binders for integration into Microsaic's water testing system.
-
Aptamer sales pipeline 'strong', more than £3m in advanced discussions
13 May 2024 10:47
(Sharecast News) - Life sciences business Aptamer said on Monday that its current sales pipeline was "strong", with over £3.0m in advanced stage discussions.
-
Aptamer applies for patent over binder sequences developed with Unilever
8 April 2024 11:25
(Sharecast News) - Aptamer Group announced the submission of a patent application safeguarding newly-crafted Optimer binder sequences on Monday.
-
Aptamer reports decent technical, commercial progress
15 December 2023 11:06
(Sharecast News) - Aptamer Group reported solid progress on both the technical and commercial fronts on Friday as it held its annual general meeting.
-
Aptamer inks £0.55m agreement with biotech firm
14 December 2023 16:43
(Sharecast News) - Aptamer Group announced a significant agreement with a biotechnology company on Thursday, focussed on genetic medicines.
-
Aptamer secures two contracts with big pharma firm
17 August 2023 15:51
(Sharecast News) - Life sciences company Aptamer Group has secured two new contracts with one of the world's top five pharmaceutical companies, it announced on Thursday, with an estimated worth of up to...
Company announcements Announcements
-
Notification of dealings by a director/PDMR
13 January 2025 11:40
Aptamer Group
-
Holding(s) in Company
30 December 2024 07:00
Aptamer Group
-
Notification of dealings by a director/PDMR
19 December 2024 16:44
Aptamer Group
-
New Development Contract
19 December 2024 07:00
Aptamer Group
-
TR-1: Standard form notification of major holdings
18 December 2024 10:53
Aptamer Group
-
Notification of dealings by a director/PDMR
16 December 2024 11:28
Aptamer Group
-
Holding(s) in Company
12 December 2024 07:00
Aptamer Group
-
Notification of dealings by a director/PDMR
9 December 2024 15:30
Aptamer Group
-
Notification of dealings by a director/PDMR
9 December 2024 13:47
Aptamer Group
-
Grant of Options and Director Fee Shares
9 December 2024 07:00
Aptamer Group
-
New Scientific Advisory Board Members
6 December 2024 07:00
Aptamer Group
-
Technical Update
5 December 2024 07:00
Aptamer Group
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2025. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.